{"id":915,"date":"2020-09-30T17:59:31","date_gmt":"2020-09-30T17:59:31","guid":{"rendered":"http:\/\/sommerconsulti.wpenginepowered.com\/?p=915"},"modified":"2021-07-29T16:00:05","modified_gmt":"2021-07-29T20:00:05","slug":"breast-cancer-awareness-month-clinical-trials-on-twitter","status":"publish","type":"post","link":"https:\/\/sommerconsulting.com\/index.php\/2020\/09\/30\/breast-cancer-awareness-month-clinical-trials-on-twitter\/","title":{"rendered":"BREAST CANCER AWARENESS MONTH + CLINICAL TRIALS ON TWITTER"},"content":{"rendered":"
\n

Clinical trials can be lifesaving for people living with breast cancer. Yet, for many, clinical trials can be the subject of criticism, skepticism, and even fear. Social media gives both patients and healthcare professionals a virtual seat at the table to share experiences and engage in conversations on these issues.<\/p>\n

If you haven\u2019t already, we encourage you to check out the amazing advocates and educators below. Join us in learning, listening, and amplifying more this #BreastCancerAwarenessMonth.<\/p>\n

Here\u2019s a look at who is talking\u2014and what they\u2019ve been saying\u2014about breast cancer and clinical trials in 2020.<\/p>\n

Patient Advocates<\/strong><\/p>\n

At Sommer Consulting, we know that it\u2019s so important to always be listening to patients. If you want to listen to patients as well, here are some great folks to start following. These advocates are active in the #bcsm (that\u2019s\u00a0breast cancer social media,\u00a0<\/em>cofounded by patient advocate\u00a0@stales<\/strong>) space. They speak out for themselves and their communities, sharing the patient perspective on clinical trials \u2013 upsides, downsides, and changes needed.<\/p>\n

Top Patient Authors by Visibility<\/strong><\/p>\n

\"\"\"\" \"\"<\/p>\n

Top Patient Advocacy Organizations by Visibility<\/strong><\/p>\n

\"\" \"\"<\/p>\n

Sample Top Tweets by Patients<\/strong><\/p>\n

\"\"\"\"<\/p>\n

Terms Most Frequently Used by Patients<\/strong><\/p>\n

\"\"\"\"<\/p>\n

Healthcare Professionals<\/strong><\/p>\n

Healthcare professionals often have a wide reach via social media and professional networks \u2014 they can often get their voices into the discourse, because when HCPs talk, people tend to pay attention. That\u2019s why it\u2019s so great when HCPs use their platforms to amplify the voices of those who may not be heard.<\/p>\n

The physicians below provide great examples of how to advocate for patients, not only in designing clinical trials but in all of healthcare. Check them out!<\/p>\n

Top HCP Authors by Visibility<\/strong><\/p>\n

\"\" \"\"<\/p>\n

Sample Top Tweets by HCPs<\/strong><\/p>\n

\"\"<\/p>\n

Terms Most Frequently Used by HCPs<\/strong><\/p>\n

\"\"<\/p>\n

What next?<\/strong><\/p>\n

Throughout #BreastCancerAwarenessMonth, we\u2019ll keep watching this space to see what new voices and topics come to the surface. We\u2019ll be amplifying both familiar and fresh voices to learn and engage with the issues that matter most to those affected by breast cancer. Join us by following @SommerConsults on Twitter.<\/p>\n

\n

Kaitlin Mikatarian<\/p>\n

Digital Linguist<\/p>\n

Sommer Consulting<\/p>\n

\"\"<\/p>\n

\n

Sommer Consulting is a boutique consulting firm specializing in custom primary qualitative research, with a strong background in women\u2019s healthcare, clinical trials, and health literacy work. Our expert linguistic team specializes in analyzing online discourse to better understand how people use social media to educate, advocate, and share healthcare experiences.<\/em><\/p>\n

To conduct this research, our team of digital linguists synthesized multiple analytics tools, developed custom lexicons, and layered on qualitative analysis to zero in on what breast cancer patients and HCPs are saying about clinical trials.<\/em><\/p>\n

Want a deeper dive into this topic? Want to investigate a different cancer type? Want to simply learn more about our tools and methodology? Please reach out and let\u2019s chat<\/em>.<\/p>\n

\n

Twitter Sources<\/p>\n

1.\u00a0https:\/\/twitter.com\/swaggsheila1\/status\/1296599256229466114<\/a><\/p>\n

2.\u00a0https:\/\/twitter.com\/akknowles1\/status\/1087527831758929921<\/a><\/p>\n

3.\u00a0https:\/\/twitter.com\/paspears88\/status\/1139725524496859136<\/a><\/p>\n

4.\u00a0https:\/\/twitter.com\/fischmd\/status\/1134535370568323072<\/a><\/p>\n

5.\u00a0https:\/\/twitter.com\/tmprowell\/status\/1234193734205571073<\/a><\/p>\n

6.\u00a0https:\/\/twitter.com\/stage4kelly\/status\/1195354876949225476<\/a><\/p>\n<\/div>\n

\n

Posted on September 30, 2020 in\u00a0Healthcare<\/a>,\u00a0Language<\/a>,\u00a0Social Media<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

As Breast Cancer Awareness Month kicks off\u2014and with COVID-19 raising the general public\u2019s awareness of and interest in clinical trials\u2014we took a look at breast cancer and clinical trials conversations in 2020 on Twitter.<\/p>\n","protected":false},"author":1,"featured_media":916,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"aside","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[21,22,24],"tags":[],"class_list":["post-915","post","type-post","status-publish","format-aside","has-post-thumbnail","hentry","category-healthcare","category-language","category-social-media","post_format-post-format-aside"],"_links":{"self":[{"href":"https:\/\/sommerconsulting.com\/index.php\/wp-json\/wp\/v2\/posts\/915","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/sommerconsulting.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/sommerconsulting.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/sommerconsulting.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/sommerconsulting.com\/index.php\/wp-json\/wp\/v2\/comments?post=915"}],"version-history":[{"count":0,"href":"https:\/\/sommerconsulting.com\/index.php\/wp-json\/wp\/v2\/posts\/915\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/sommerconsulting.com\/index.php\/wp-json\/wp\/v2\/media\/916"}],"wp:attachment":[{"href":"https:\/\/sommerconsulting.com\/index.php\/wp-json\/wp\/v2\/media?parent=915"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/sommerconsulting.com\/index.php\/wp-json\/wp\/v2\/categories?post=915"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/sommerconsulting.com\/index.php\/wp-json\/wp\/v2\/tags?post=915"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}